Early research (Phase 1)Looking for participantsNCT05988463What this trial is testingDose-Escalation Study of Artesunate Patients With IPFWho this might be right forIdiopathic Pulmonary Fibrosis Joseph C. Wu 15
Not applicableNot Yet RecruitingNCT07722507What this trial is testingAntifibrotic Therapy Decision-Making in Pulmonary FibrosisWho this might be right forPulmonary FibrosisIdiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis Bristol-Myers Squibb 40
Not applicableStudy completedNCT05779007What this trial is testingDose Reduction and Discontinuation With Anti-Fibrotic MedicationsWho this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim 2,778
Testing effectiveness (Phase 2)Study completedNCT02477709What this trial is testingAssess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 6
Not applicableLooking for participantsNCT01776398What this trial is testingCollection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesWho this might be right forChronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3 more Weill Medical College of Cornell University 2,000
Early research (Phase 1)Study completedNCT01254409What this trial is testingA Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Hoffmann-La Roche 21
Not applicableWithdrawnNCT05676112What this trial is testingSafety of Nintedanib in Real World in ChinaWho this might be right forPulmonary Fibrosis Boehringer Ingelheim
Testing effectiveness (Phase 2)Ended earlyNCT06097260What this trial is testingRandomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Pliant Therapeutics, Inc. 320
Testing effectiveness (Phase 2)Looking for participantsNCT06951217What this trial is testingAn Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)Who this might be right forProgressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF) Avalyn Pharma Inc. 340
Not applicableStudy completedNCT02055222What this trial is testingClinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung DiseaseWho this might be right forPulmonary FibrosisLung Disease National Heart, Lung, and Blood Institute (NHLBI) 7
Not applicableStudy completedNCT01134822What this trial is testingProspective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)Who this might be right forIdiopathic Pulmonary Fibrosis University of Nottingham 330
Testing effectiveness (Phase 2)Ended earlyNCT06360094What this trial is testingTest Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis Boehringer Ingelheim 85
Early research (Phase 1)Study completedNCT05427253What this trial is testingFirst-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy SubjectsWho this might be right forSafety IssuesToleranceIdiopathic Pulmonary Fibrosis+1 more Vicore Pharma AB 80
Large-scale testing (Phase 3)Ended earlyNCT03733444What this trial is testingA Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of CareWho this might be right forIdiopathic Pulmonary Fibrosis Lakefront Biotherapeutics NV 781
Not applicableStudy completedNCT05173571What this trial is testingHomecare Integral Support Program for IPF PatientsWho this might be right forIdiopathic Pulmonary Fibrosis Institut d'Investigació Biomèdica de Bellvitge 95
Not applicableLooking for participantsNCT07174102What this trial is testingRadiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed TomographyWho this might be right forReumatoid ArthritisInterstitial Lung Disease Due to Systemic Disease (Disorder)Idiopathic Pulmonary Fibrosis (IPF)+1 more Azienda Unita Sanitaria Locale di Piacenza 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06132256What this trial is testingMAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Syndax Pharmaceuticals 145
Not applicableStudy completedNCT05366387What this trial is testingEffect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis University Hospital, Tours 9
Not applicableNot Yet RecruitingNCT07178392What this trial is testingDisease-syndrome Characteristics of IPFWho this might be right forIdiopathic Pulmonary Fibrosis (IPF) Henan University of Traditional Chinese Medicine 2,864
Early research (Phase 1)Study completedNCT04720443What this trial is testingA Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal SubjectsWho this might be right forIdiopathic Pulmonary Fibrosis The National Institutes of Pharmaceutical R&D Co. Ltd, China 56